Market Tracker

07/25 3:56am ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

0.245
Delayed Data
As of Jul 22
 -0.0278 / -10.19%
Today’s Change
0.20
Today|||52-Week Range
7.97
-92.07%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close0.27
Today’s open0.22
Day’s range0.22 - 0.27
Volume1,128,545
Average volume (3 months)1,195,017
Market cap$6.4M
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+58.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratioNM
Price/Sales100.27
Price/Book0.16

Competitors

 Today’s
change
Today’s
% change
SSKNSTRATA Skin Sciences...0.000.00%
TLOGTetraLogic Pharmaceu...-0.07-22.47%
BSPMBiostar Pharmaceutic...+0.07+1.75%
CPHIChina Pharma Holding...+0.04+14.09%
Data as of 07/22/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Independent Director
Scott M. Rocklage
Secretary, Senior Vice President &
General Counsel
Robert Ticktin
Corporate headquarters
Boston, Massachusetts

Forecasts